Dabigatran superior to warfarin when anticoagulation is resumed after bleeding

(University of Pittsburgh Schools of the Health Sciences) In the first analysis of how to treat patients on anticoagulants who suffer a major bleeding event, a clinical practice that routinely gives doctors pause, while also evaluating a new drug, University of Pittsburgh researchers aim to provide much-needed guidance to clinicians trying to balance the risks of stroke versus bleeding when determining the best treatment.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2fXg1G7